Bococizumab (PCSK9/NARC1/ PC9) - Research Grade Biosimilar
Product Specifications
Background
Bococizumab has been used in trials studying the treatment and prevention of Dyslipidemia, Hyperlipidemia, Hypercholesterolemia, Cardiovascular Disease, and Heterozygous Familial Hypercholesterolemia.
Immunogen
Humanized / PCSK9/NARC1/ PC9 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG2-kappa
NCBI Organism
Homo sapiens
Other Product Names
PF-04950615, RN-316
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-1880R-BF555-TR 20 µL
PTGEs/Prostaglandin E Synthase Polyclonal Antibody, AbBy Fluor™ 555 Conjugated
Sign In for Pricing
View Details 
